Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD) Investor Relations Documents

Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD) investor relations documents from the company's IR site: 4 presentations, 36 press releases; latest deck 2026-03-27. Read in-app with summaries. First-party data.

Download Latest Presentation — Aethlon Medical’s Hemopurifier® is a blood-filtration platform targeting cancer and viral threats, currently in clinical trials for oncology applications.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-13Press releaseAethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
2026-08-13Press releaseAethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
2026-08-05Press releaseAethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
2026-08-05Press releaseAethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
2026-07-13Press releaseAethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluati
2026-07-13Press releaseAethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluati
2026-07-06Press releaseAethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
2026-07-06Press releaseAethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
2026-06-26Press releaseAethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the
2026-06-26Press releaseAethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the
2026-06-10Press releaseEarnings Release HTML
2026-06-10Press releaseEarnings Release FY 2026 PDF
2026-06-02Press releaseAethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
2026-06-02Press releaseAethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
2026-05-21Press releaseAethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
2026-05-21Press releaseAethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
2026-03-27PresentationDownload Latest Presentation
2026-03-24Press releaseAethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
2026-03-24Press releaseAethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
2026-03-12Press releaseAethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
2026-03-12Press releaseAethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
2026-02-23Press releaseAethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
2026-02-23Press releaseAethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
2026-02-12Press releasePDF
2025-11-12Press releasePDF
2025-08-13Press releasePDF
2025-07-15Press releaseAethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clini
2025-07-15PresentationKeystone Symposia Poster Presentation - Long COVID and Other Post-Acute Infection Syndromes
2025-06-26Press releasePDF
2025-06-20Press releaseAethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025
2025-02-24PresentationAethlon Corporate Overview – February 2025
2025-02-12Press releaseAethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate
2025-02-12Press releasePDF
2025-02-05Press releaseAethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025
2024-11-13Press releaseAethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporat
2024-11-13Press releasePDF
2024-11-06Press releaseAethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024
2024-09-17PresentationAethlon Corporate Overview – September 2024
2024-08-27Press releaseAethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular V
2024-08-14Press releasePDF

AEMD overview · AEMD earnings · AEMD financials · AEMD KPIs · AEMD ownership · AEMD peers · AEMD filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.